| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.4 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |